Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in increased chloride ion conductance, neuronal hyperpolarization, and reduction in neuronal excitability.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Preanesthetic medication
* Management of seizures, including status epilepticus
* Symptomatic relief of anxiety associated with depression
## Adult Dosing
* **Anxiety:** 1-4 mg orally or IM every 6-8 hours as needed.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Preanesthetic Medication:** 2-4 mg IM or IV 2 hours before surgery. For pre-operative anxiolysis, 0.05 mg/kg IM (maximum 4 mg) may be given up to 2 hours before surgery.
* **Status Epilepticus:** 4 mg IV initially. If seizures persist or recur within 10-15 minutes, a second dose of 4 mg IV may be administered. Do not exceed 8 mg total in status epilepticus without further medical supervision.
* **Intramuscular (IM) Use:** 4 mg IM once; may repeat in 2 hours if necessary.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be determined by specific indication and patient factors.
* **Status Epilepticus:** 0.1 mg/kg IV (maximum 4 mg per dose), may repeat in 5-10 minutes if seizures persist.
* **Anxiety/Sedation:** Doses range from 0.02-0.05 mg/kg/dose IV/IM/PO every 4-6 hours, with careful titration and monitoring.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require lower doses.
* **Renal Impairment:** No specific dose adjustment is routinely recommended, but caution is advised.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute angle-closure glaucoma.
* Severe respiratory insufficiency.
* Severe liver insufficiency.
* Myasthenia gravis (relative contraindication, avoid if possible).
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, sedation.
Less common: Confusion, depression, amnesia, paradoxical excitement, slurred speech, blurred vision, nausea, rash.
Rare: Respiratory depression (especially with IV administration or in combination with other CNS depressants), hypotension, paradoxical excitation, withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedatives, anesthetics):** Additive CNS depression, potentially leading to severe sedation, respiratory depression, coma, and death. Use with extreme caution and consider reduced doses of one or both agents.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproate:** May increase plasma concentrations of lorazepam.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, so interactions with CYP enzymes are less common but still possible.
## Monitoring
* Assess for intended therapeutic effects (e.g., reduced anxiety, improved sleep, seizure control).
* Monitor for adverse effects, particularly drowsiness, dizziness, and cognitive impairment.
* Monitor respiratory rate and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Evaluate for signs of dependence or withdrawal if used long-term or at high doses.
## Clinical Pearls
* Lorazepam has a longer half-life than some other benzodiazepines, which can be advantageous for sustained effects but may also contribute to residual daytime sedation.
* Intravenous lorazepam can cause propylene glycol toxicity, especially with prolonged infusions or high doses.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms, including anxiety, insomnia, tremors, muscle cramps, and in severe cases, seizures. Tapering is recommended.
* When used for status epilepticus, IV administration is preferred for faster onset of action.
* Elderly patients are more sensitive to the sedative and disorienting effects of benzodiazepines and may require lower doses.
***
*Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before administering any medication. Dosing and management may vary based on patient-specific factors and institutional protocols.*
